We used magnetic resonance imaging with cine velocity mapping to study the anatomy of pulmonary bifurcation and to measure volume blood flow, pulsatility of flow and arterial wall distensibility in the central pulmonary arteries of nine healthy volunteers. Multislice, multiplane spin echo images were acquired to display pulmonary bifurcation anatomy. Diameters of the main pulmonary artery (MPA) in systole were 2.56 +/- 0.35 cm and in diastole 2.20 +/- 0.33 cm. Those of the right pulmonary artery (RPA) were 1.57 +/- 0.29 cm and 1.39 +/- 0.23 respectively, and of the left pulmonary artery (LPA) 1.79 +/- 0.26 cm and 1.55 +/- 0.10 cm respectively. A gradient echo sequence with phase shift velocity mapping was then used to measure flow in MPA, RPA and LPA 2 cm on either side of the pulmonary bifurcation. Time averaged flow, calculated from mean velocity and the cross-sectional area of the vessels was 4.99 +/- 1.10 l.min-1 in MPA, 2.23 +/- 0.58 l.min-1 in RPA and 2.31 +/- 0.63 l.min-1 in LPA. The pulsatility index of flow derived from peak forward flow, peak backward flow and time averaged flow were as follows: MPA 4.4 +/- 0.8, RPA 5.1 +/- 0.6 and LPA 4.6 +/- 1.5. Distensibility, calculated from the change in cross-sectional area between diastole and systole and expressed as percentage were as follows: MPA 25.6 +/- 10.7, RPA 21.4 +/- 10.7 and LPA 24.5 +/- 7.8. MRI with velocity mapping accurately characterized anatomy, flow, distensibility and pulsatility of the central pulmonary arteries.

Aims To compare the serum pharmacokinetics of fosinoprilat with enalaprilat and lisinopril after 1 and 10 days of dosing with fosinopril, enalapril and lisinopril. Methods Patients with congestive heart failure (CHF, NYHA Class II–IV) and chronic renal insufficiency (creatinine clearance ≤30 ml min−1 ) were randomized to receive fosinopril, enalapril or lisinopril in two parallel‐group studies. In the first study 24 patients were treated with 10 mg fosinopril (n=12 patients) or 2.5 mg enalapril (n=12) every morning for 10 consecutive days. In the second study 31 patients were treated with 10 mg fosinopril (n=16 patients) or 5 mg lisinopril (n=15) every morning for 10 consecutive days. Samples of blood were collected for determination of pharmacokinetic parameters. The area under the curve (AUC) between the first and last days of treatment and the accumulation index (AI) were the primary outcome measures. Results All three angiotensin converting enzyme (ACE) inhibitors exhibited a significant increase in AUC between the first and last days of treatment in both studies. The difference between the AI for fosinoprilat (1.41) and enalaprilat (1.96) was statistically significant (95% CI: 1.05, 1.84). Similarly, the difference between the AI for fosinoprilat (1.21) and lisinopril (2.76) was statistically significant (95% CI: 1.85, 2.69). All three ACE inhibitors completely inhibited serum ACE for 24 h. All treatments were well tolerated. Conclusions Fosinoprilat exhibits significantly less accumulation than enalaprilat or lisinopril in patients with CHF and renal insufficiency, most probably because fosinoprilat is eliminated by both the kidney and liver, and increased hepatic elimination can compensate for reduced renal clearance in patients with kidney dysfunction.

The ingestion of a small amount of ethanol caused an increase in the gradient across the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy, which could have and adverse clinical effect.

Mitral annulus calcification has been associated with embolic events, but the precise pathophysiology has not been elucidated. The authors describe four patients who experienced embolic events whose transesophageal echocardiograms showed a mitral annulus calcification, with a mobile component that exhibited the same echogenicity as the calcification. Three patients had no other conditions known to be associated with embolism. On follow-up transesophageal echocardiography, the mobile component of the mitral annulus calcification had disappeared in three patients. These findings support the hypothesis that mitral annulus calcification not only is associated with but also is possibly a direct cause of embolic events in some patients.

Bilateral multiple hamartomas were found in a woman suspected of having metastatic malignancy of the lung. As extensive investigation for the primary tumour was unrevealing, a left exploratory thoracotomy and histological examination established the diagnosis. In view of the benign character of the tumours, local excision alone was performed. No surgical intervention was performed on the right side. Repeat chest films 12 months after surgery did not show the appearance of new lesions in the left lung or any increase in the size of the nodules in the right lung. This is the 12th case so far reported. The clinical characteristics and surgical management of these tumours are discussed.